Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice.
Santoro MM, Di Carlo D, Armenia D, Zaccarelli M, Pinnetti C, Colafigli M, Prati F, Boschi A, Antoni AMD, Lagi F, Sighinolfi L, Gervasoni C, Andreoni M, Antinori A, Mussini C, Perno CF, Borghi V, Sterrantino G.
Santoro MM, et al. Among authors: sterrantino g.
Antivir Ther. 2018;23(3):249-257. doi: 10.3851/IMP3197.
Antivir Ther. 2018.
PMID: 28935850